-
Most Recent
Search Results
240 results for fsa
NVAX Stock Alert: 14 Things to Know as the Novavax Vaccine Faces the FDA Today
Novavax (NVAX) stock is in the news today as investors prepare for the results from the vaccine company’s meeting with the FDA.
FSR Stock: Fisker Shares Surge on BIG Analyst Call
FSR stock is surging because one Citigroup analyst just delivered a massive price target. Here is what you need to know now.
Amazon Delivery Drones Get FAA OK for Outside Testing
Amazon delivery drones have been approved for outside testing by the FAA, but there are several limitations to on the approval.
FAA Recalls 800 Airline Inspectors From Furlough
The FAA says that 800 of the 3,000 aviation inspectors furloughed due to the government shutdown will return to work this week.
Trade of the Day: ASA Ltd. Pullback Offers Golden Opportunity
The future is bright for ASA, as recent profit pullbacks could mean attractive long-term earnings.
Bank of America Corp Takes a Shot at the Power (BAC)
Tired of taking penalties from the FHA, Bank of America Corp is starting a program tailored to low- and moderate-income mortgages to borrowers.
FSR Stock Alert: Fisker Slashes Output Forecast
Start-up EV maker Fisker has sharply reduced its production forecast. FSR stock is sinking over 7% on the news.
FSR Stock Alert: Fisker Receives Non-Compliance Notice From NYSE
Fisker stock is falling on Tuesday as FSR investors react to a non-compliance notice and the resignation of its new CAO.
Teething Warning: FDA Warns Parents to Stop Using These Remedies
The FDA is warning parents against using homeopathic teething tablets and gels to treat infants and children due to possible risks.
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.
Back Up the EV in Fisker Shares Today
FSR stock has crashed with the best of them and today is offering a nice spot to pick up growth at a sizable and attractive-looking…
7 Undervalued Stocks to Buy With a Dividend Yield of Over 7%
These are the undervalued stocks to buy as they represent companies with strong fundamentals and a robust dividend yield
Novavax Stock Can Rally, But It’s Still Facing Many Obstacles
Novavax’s vaccine will likely be approved by the FDA relatively soon, but NVAX stock is still facing many obstacles.
A Wall Street Analyst’s Nod has Boosted Confidence in Fisker Stock
Someone just slapped a $40 price target on FSR stock. That’s ambitious, no doubt, but the facts may justify a massive share-price move.
How to Pick Up Fisker Shares at a Discount
Fisker shareholders haven’t been alone in their misery, but looking forward there are reasons to be upbeat on FSR stock
Short-Sellers Beware — Fisker Could Rocket Up 200%
FSR Stock has already risen over 65% since its listing. Short-sellers should watch out — here’s why another 200% gain could be coming.
FSR Stock Could Be the Top Short Squeeze Stock Now
Fisker is in focus as the short interest in FSR stock (and the entire market) continue to attract investors’ attention.
GILD Stock: FDA Greenlights Gilead Sciences, Inc. Hep-C Drug Epclusa
Gilead Sciences (GILD) stock is up big Tuesday after the FDA granted its drug, Epclusa, approval for use in chronic HCV patients.
3 BDCs to Buy for Their Big, Fat Yields
Middle-market companies need to grow, and that’s what fuels BDCs’ high-single-digit and even double-digit yields to shareholders.
Bluebird Bio (BLUE) Stock Is in Focus Following FDA Approval
The Boston-based biotech company has secured FDA approval for one of its gene therapies. Let’s take a closer look at BLUE stock.
Fisker Shares Could Begin Moving Higher as Production Ramps Next Year
Fisker stock could begin moving higher as production ramps next year. FSR stock could rise 27% next year as the company approaches production, especially now…
Novavax Stock Is in Prime Position For Speculation
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on…
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts.
Oh Baby! OWLT Stock Plunges 20% Following FDA Warning Letter
Today, an FDA warning letter has sent shares of OWLT stock plunging, as investors become uncomfortable with this baby products maker.
10 – 10 of 240 results
